未登录

B

Brian Wigdahl

drexel university

H指数:45

被引数:7,739

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir

突破HIV-1的表观遗传保险库：消除病毒库的治疗策略

IF3.5

2026-03-130

OAAI

Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat

炎症小胶质细胞信号即使在HIV-1 Tat存在的情况下也能驱动星形胶质细胞的A1样极化

Molecular Neurobiology

IF4.3

2025-12-040

OAAI

Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach

单纯疱疹病毒1型感染的免疫学控制：一种基于非热等离子体的方法

IF3.5

2025-04-230

OA

Impact of chromatin on HIV-1 latency: a multi-dimensional perspective

组蛋白对HIV-1潜伏期的影响：多维度视角

EPIGENETICS & CHROMATIN

IF3.5

2025-03-080

OA

Delivering CRISPR to the HIV-1 reservoirs

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-05-151

OAAI

Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease

IF10.8

2024-02-011

OAAI

Roles of neuropathology-associated reactive astrocytes: a systematic review

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2023-03-13130

OAAI

IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers

IgG N-聚糖标记作为潜在的诊断和预后生物标志物

IF3.3

2023-03-0714

OAAI

Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy

IF3.9

2023-01-033

OAAI

Examining virtual driving test performance and its relationship to individuals with HIV-associated neurocognitive disorders

FRONTIERS IN NEUROSCIENCE

IF3.2

2022-08-242

OAAI

Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-08-056

OAAI

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

靶向CCR5作为HIV-1治疗策略的组成部分

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-2040

OAAI

HIV-1 cure strategies: why CRISPR?

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2021-02-0722

OA

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2020-09-0115

OAAI

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-08-1214

OAAI

Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2020-06-2344

OAAI

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND

细胞外HIV-1 Tat介导中枢神经系统中谷氨酸的增加，导致衰老和手的发展

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2020-06-0926

OAAI

The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook

树突状细胞免疫治疗HIV-1感染的进展与展望

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2020-05-2511

OAAI

HIV-1 Tat Length: Comparative and Functional Considerations

HIV-1 Tat长度: 比较和功能考虑

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-03-2417

OAAI

Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency

MOLECULAR THERAPY

IF12

2020-01-0125

OAAI